JESSE M CARTER, JR.
Medical Practice in Tampa, FL

5516700, May 14, 1996

Apr 24, 1995

8/429292

Jack V. Smith - St. Peter FL
Jesse M. Carter - Tampa FL

Chimera Research and Chemical, Inc. - Largo FL

G01D 2175

436164

A method that provides techniques for determination of urinary constituents (Blood (Red Blood Cells/Hemoglobin), Leukocytes, pH, Specific Gravity, Bacterial Reductase/Nitrite/Indole activity, Total Ketone Bodies, Protein, and Glucose) at low chemically significant levels with a carrier independent reagent system that can be placed on a high throughput autoanalyzers. Thus, giving the analyst the ability to run multiple urinary assays on a single sample of urine simultaneously with the ability to compare to reference standards on the same run. This system is designed to neutralize urinary interfering substances. This method is fast, efficient, an adaptable to many of the currently available discrete and continuous flow automated analyzers, effective at sample to reagent ratios of 1 to 13 or more. This method is applicable to samples with high turbidity, high ionic strength, high color content, wide pH extremes, and buffer strengths, among other interfering substances.

5736408, Apr 7, 1998

Feb 14, 1996

8/599988

Jesse M. Carter - Tampa FL
Jack V. Smith - St. Pertersburg FL

G01N 3300

436 97

Method of detecting urobilinogen in urine using a chemical detection means with an indicator that will produce a detectable quantitative response in the presence of, or lack of urobilinogen in urine on an automated analyzer.

5776780, Jul 7, 1998

Apr 12, 1996

8/631581

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

Chimera Research & Chemical, Inc. - Largo FL

G01N 33493

436 63

Detecting white blood cells in an aliquot of urine by placing the aliquot of urine in an automated analyzer sampling cup, transferring the urine to a cuvette and injecting at least one reagent composition. The reagent composition contains a buffer, an activator such as benzalkonium chloride, an indicator and at least one substance to remove substances in the urine that cause interference with colorimetric photometry. The aliquot of urine is read in accordance with a preprogrammed code at a monochromatically specified wavelength to compare absorbance of the patient's urine with a known standard containing a known concentration of white blood cells.

5955374, Sep 21, 1999

Jan 29, 1996

8/591959

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

G01N 3300

436 97

Method for detecting total bilirubin in urine using a chemical detection means with an indicator that will produce a detectable quantitative response in the presence of bilirubin in urine on an automated analyzer.

2003013, Jul 24, 2003

Jan 17, 2002

10/051845

Jesse Carter - Tampa FL, US
Robert Immekus - Tampa FL, US

G01N035/00, G01N021/78

436/043000, 436/901000, 436/164000, 436/171000, 422/068100, 422/082050, 422/082090, 422/063000

This invention relates to a reagent for use in determining the presence of oxidizing adulterants in urine being screened for drugs of abuse. This invention is useful in automated spectrophotometric analyzers used in screening urine for drugs of abuse.

5500954, Mar 26, 1996

Apr 29, 1994

8/236656

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

J. Prime Industries, Inc. - St. Petersburg FL

A41D 1300, A61F 904

2 9

A safety system shield which protects the head, facial, throat, and upper thorax regions of the body from exposure to biological, chemical, and physical matter that may take the form of solids, liquids, or aerosols, and includes a thin flexible shield which is curved, and transparent. It is shaped to rest on the anterior shoulder, and thorax region of the body, thereby allowing the head to look in any direction. This relieves the wearer's head of the weight of the shield while affording maximum protection. The safety shield system is ultra-light weight thus, reduces wearer's fatigue, and eliminates headaches, resulting in the enhancement of safety, and the reduction of accidents. The safety shield is flexible allowing it to conform to the size, and curvature of the wearer.

6304174, Oct 16, 2001

Dec 11, 1995

8/570605

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

B60Q 152

340471

There is herein described an emergency auto visual communication system that will enhance roadway, vehicular, and individual safety. A stranded motorist, accident victim, medical emergency, etc. is provided a viable means for communication of the situation to a casual observer, or proper authorities, precisely, and rapidly without having to leave the safety and confines of the vehicle. That is, the invention provides an advantageous means to prevent loss of life, save precious seconds, and provide the individual in need the proper help by use of the illuminated electronic message board attached to the rear window of a vehicle controlled by a alpha-numeric computer keyboard.

5733785, Mar 31, 1998

Jan 23, 1997

8/787623

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

Chinera Research Chemical, Inc. - Largo FL

G01N 2178, G01N 33493

436 66

Detecting red blood cells in a patient's urine by placing an aliquot of the urine in an automated analyzer sampling cup. The urine is transferred to a cuvette mounted within the automated analyzer and one or more reagent compositions in an aqueous medium is injected into the cuvette. The reagent contains a buffer to adjust pH, chemicals to remove substances in the urine that interfere with colorimetric photometry, a compound to lyse the red blood cells in the urine, a substrate to react with the hemoglobin, a color indicator and a surfactant to improve fluid mechanics. The sample is read against a standard using a pre-programmed monochromatically specified wavelength to determine the presence or absence of blood cells in the patient's urine.

5801059, Sep 1, 1998

Mar 19, 1996

8/616479

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

Chimera Research & Chemical, Inc. - Largo FL

G01N 33493

436128

Aliquot of a urine sample is placed in a first automated analyzer sampling cup and a known standard is placed in a second cup. The urine sample and standard are transferred to separate cuvettes and at least one reagent composition in an aqueous medium is injected into the cuvette. The reagent composition contains a compound to remove substances in the urine interfering with a calorimetric reaction, a compound to convert B-hydroxybutyric acid in the urine to acetoacetic acid in the presence of nicotinamide adenine dinucleotide and reading at a specified wavelength to determine quantitatively the total ketone bodies in the patient's urine.

D377850, Feb 4, 1997

Sep 13, 1995

D/043886

Jack V. Smith - St. Petersburg FL
Jesse M. Carter - Tampa FL

Chimera Research & Chemical, Inc. - Tampa FL

D29108